加载中
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
常规交易时段
US$2.9797
−US$0.4303 · -12.62%
盘中时间采用ET。市场数据可能有所延迟。
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
日内区间
当前US$2.9797
52周区间
当前US$2.9797
盘中时间采用ET。市场数据可能有所延迟。
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
日内区间
当前US$2.9797
52周区间
当前US$2.9797
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 394.4万 USD | 327.7万 USD | 292.8万 USD | 69.1万 USD | 16万 USD |
| 销货成本 | 158.6万 USD | 156.6万 USD | 168.7万 USD | 133.2万 USD | 5.5万 USD |
| 毛利 | 235.8万 USD | 171.1万 USD | 124.1万 USD | −64.1万 USD | 10.5万 USD |
| 研究与开发 | 214.9万 USD | 260.3万 USD | 316.3万 USD | 282.8万 USD | 171.8万 USD |
| 销售、一般及管理费用 | 1300.1万 USD | 1287.4万 USD | 1380.5万 USD | 1525.6万 USD | 484.8万 USD |
| 营业费用 | 1515万 USD | 1547.7万 USD | 1696.8万 USD | 1808.4万 USD | 656.6万 USD |
| 利息支出 | — | 3.4万 USD | 2.1万 USD | 35.4万 USD | 62.1万 USD |
| 折旧和摊销 | 53万 USD | 65.5万 USD | 42.6万 USD | 28.9万 USD | 11.4万 USD |
| 营业利润 | −1279.2万 USD | −1376.6万 USD | −1572.7万 USD | −1872.5万 USD | −646.1万 USD |
| 净利润 | −1255.6万 USD | −1367.3万 USD | −1558.1万 USD | −1891.7万 USD | −704.8万 USD |
公司数据更新于 2026年10月12日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
报告持有此股票敞口的交易所交易基金。
AI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
